Market Size (2015)
2015
$11.70B
Vertical: HealthcareBase Year: 201713 Sections
Market Size (2015)
2015
$11.70B
Projected (2023)
2023
$65.74B
CAGR (2015–2023)
24.1%
24.1%Key Players
100+
Dental tourism is becoming a popular trend in developed countries such as the US and the UK where costs associated with dental procedures are comparatively high. Developing countries such as Costa Rica, Hungary, and India are providing the same dental treatments at affordable prices. An average patient saves approximately 50 to 70% on dental treatment when he/she opts for dental tourism. The factors that are anticipated to propel the growth of the global dental tourism market include the availability of low-cost dental services in developing countries, increasing awareness about dental tourism, and increasing number of medical tourism companies. Moreover, language barriers, issues related to the continuity of care, and concerns about the quality of cross-border dental care may hinder the growth of the market during the forecast period.
The global dental tourism market is expected to reach USD 28221.43 million by 2023 from USD 17900.94 million in 2017 and is expected to register a CAGR of 24.27% during the forecast period from 2018 to 2023. In 2017, the market was led by the Europe with a 40.0% share, followed by Asia-Pacific and Americas with shares of 35.9% and 22.1%, respectively.
The global dental tourism market has been segmented based on dental procedure.
On the basis of dental procedure, Dental Implants accounted for the largest market share of 37.5% in 2017, with a market value of USD 6710.11 million, which is projected to register a CAGR of 23.21% during the forecast period.
The Dental Tourism Market market is projected to grow at a CAGR of 24.1% from 2015 to 2023.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDental tourism is a branch of medical tourism. In this, patients with dental problems travel to other parts of the world or country to carry out dental procedures or treatments. The primary objective of dental tourism is to get good quality treatment at affordable cost. Dental tourism is popular in developed countries such as the UK and the US, where patients travel to the nearest developing countries such as Mexico, Costa Rica (US), and Hungary (UK) for dental treatments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2017
Historical Period
2015 – 2017
Forecast Period
2017 – 2023
Primary Interviews
150+
Historical data (2015–2017) and forecast period (2017–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansBargaining Power of Suppliers
The bargaining power of suppliers is moderate to high in the global dental tourism market. There are a large number of hospitals & clinics and dental services providers across the globe. But some of them are renowned and well established in this market. Some major factors increase the bargaining power of the suppliers in this market such as high-quality services, Accreditation of various organization and brand name. Less waiting time and easy access to their services also play an important role which can give them the edge over the bargaining power of the buyers. Hospitals and dental clinics are investing a large amount of money for marketing that helps them to reach their target audience i.e. dental tourists. Moreover, websites are the very effective medium of information that can affect the bargaining power of suppliers.
Bargaining Power of Buyers
The bargaining power of buyers is medium in the global dental tourism market. The bargaining power of buyer depends on how easily an individual can get dental service or product. Patients from different nations have various options to choose from. The buying decision of consumer is mainly depending on the cost of the dental procedure, quality of the dental treatment, waiting period, and reputation of the hospitals or dental clinic. Consumers of this market are highly price sensitive and this factor raises the bargaining power of the buyer. Patients want high-quality services at lower prices. Due to intense competition, dental tourism providers are offering cost-effective and high-quality services to the patients to attract more dental tourists.
Threat of New Entrants
In the global dental tourism market, the threat of new entrant is moderate to high. There some renowned health services providers in this market, most of them are located in the Asia-Pacific region, some in the Americas and some parts of Europe. Dental services providers are expanding their reach by establishing the chain of dental clinics which can give them the edge over the new entrants. The high success rate of treatments, specialty, cost, and high-class infrastructure can reduce the threat of new entrants. However, this industry is growing rapidly which attracts more new players in this market. Emerging dental services providers are investing money in technology advancement, infrastructure, marketing, and collaboration to enter this market, these are some factors that are increasing the threat of new entrants.
Threat of Substitutes
In the global dental tourism market, the threat of substitute is low. A dental tourist travels to another country mainly due to the cost-effectiveness of the dental procedure, and unavailability of the services in their home country. Many hospitals and dental clinics are providing affordable dental services to retain their patient base which creating a threat of substitute for this market. However, patients can change their mind to travel abroad for treatments due to some major factors such as government support to provide affordable healthcare and extended insurance cover. Moreover, government and dental service providers are also encouraging domestic or intrabound dental travel that can be a substitute for the global dental tourism industry.
Intense Rivalry
The intensity of rivalry is moderate to high in the global dental tourism market. Dental services providers are expanding their offering and network to attract more and more dental tourists which increase the intensity of the rivalry. Specialty dental treatment offering and patient’s dissatisfaction regarding the dental services may benefit the competitors present in this market.
Market estimates by geography (2023)
InsightEurope leads with $28.22B by 2023, while Asia Pacific is projected to grow fastest at a 26.3% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $321.75M | $412.37M | $528.51M | 6.4% | 1% |
| Americas | $2.82B | $5.54B | $10.89B | 18.4% | 17% |
| Asia Pacific | $4.03B | $10.26B | $26.10B | 26.3% | 40% |
| Europe | $4.53B | $11.30B | $28.22B | 25.7% | 43% |
| Total | $11.70B | $27.51B | $65.74B | 24.1% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Dental Tourism Market covering market dynamics, competitive landscape, and strategic outlook.
The Dental Tourism Market market is projected to reach $65.74B by 2023, growing at 24.1% CAGR.
Dental tourism is an important aspect of medical tourism. When dental patients visit from one country to another for dental care for the availability of cheap dental procedures or for expertise which lacks in their own country, then this practice is termed as dental tourism. Additionally, the dental tourism market has seen an upsurge in the recent years owing to the increasing number of patients traveling to foreign destinations to seek low-cost dental treatments.
The market for dental tourism has both positive factors and negative factors which affect the growth of the market. Some of the factors that drive the growth of the market include the low cost of dental treatments in less developed countries, lack of insurance coverage in industrialized countries, and increasing awareness about the potential of dental tourism. On the other hand, growing concerns about the quality of cross-border dental services and issues about after service dental care can act as hurdles for the growth of the market in the coming years.
Dental tourists mainly travel for low-cost dental care. Dental treatments in developed countries such as the US, Canada, the UK, and Japan are becoming expensive and thus tourists seek dental care in developing countries in order to save money. According to the United Nations World Tourism Organization (UNWTO), a medical vacation can cost up to 50%, 30%, or even 10% of what an individual would normally pay at the home country, depending on the location and procedure. For instance, a simple dental filling can cost around USD 400 in the US, whereas dental patients can get the same treatment done in India for about USD 40. Similarly, dental implants cost about USD 4000 in the US, about USD 3500 in the UK, whereas in Mexico, Costa Rica, and Colombia the same procedure costs approximately USD 850. Thus, the price is evidently the major driving force towards the growth of the dental tourism industry.
Countries such as Mexico, Costa Rica, Thailand, India, and countries in eastern Europe are considered to be major hubs for dental tourism. Dental tourism is a booming industry in developing countries as each dentist is trying to create cost-effective dental services in order to attract foreign patients. Moreover, such travels are being assisted by the growth of low cost/budget airlines providing access to cheaper dental tourism destinations. In addition to this, dental patients always combine treatment with sightseeing during their visit to the dental tourism country which further contributes to the growth of the market.
Dentists and dental tourism companies can come together to build a mutually beneficial network that has patients’ interest. Dental care facilities can collaborate with such companies to increase their business and thus attract a number of tourists. Moreover, as dentists are involved in the process, dental tourists looking for certain requirements can get complete insight about the dental services which can help them in selecting the correct dental tourism destination. Thus, strategic collaborations between dental facilities and dental tourism companies can provide huge opportunities for the market to propel during the forecast period.
Cross-border dental care generally allows patients to receive affordable and competent care. However, the most salient issue is the quality of care patients receive in foreign countries. Licensing and accreditation of dentists, regulation of dental clinics, quality of dental education, training of assistants, selection of dental equipment and supplies, and other factors can overall affect the quality of care. Patients crossing borders in search of low-cost procedures might be at a greater risk of receiving substandard treatment. Moreover, patients might have less insight into the quality of treatment they will receive abroad. In addition to this, the risk of receiving dental procedures which are not required further increases the concern about dental tourism.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 100 companies operating in the Dental Tourism Market market, including revenue, employee count, and market positioning where available.
Showing 100 of 100 companies
Novavax, Inc.
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Ology Bioservices, Inc
Company Headquarters: Florida, US Founded: 1999 Workforce: ~800 Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments. Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).
Cleveland Biolabs, Inc
Company Headquarters: New York, US Founded: 2003 Workforce: ~150 Company Working: Cleveland Biolabs, Inc. is an innovative biopharmaceutical company developing products to address immune system diseases and serious medical needs. It is specialized in offering products such as radiation injury products, immune-oncology, and orphan drugs. It has nine product candidates in its pipeline that have been developing directly through itself or its wholly owned companies, namely Incuron, LLC (US) and Panacela Labs, Inc. (US). It has a proprietary platform, namely the Advanced Immunomodulating Multi-Receptor System (AIMS) platform, which is designed to restore immune homeostasis. Moreover, it has collaboration with government agencies which supports the advanced development and procurement of new medical countermeasures including drugs, vaccines, diagnostics, and medical supplies in order to protect public health from chemical, biological, radiological, and nuclear threats.
Fabentech Biotech
Company Headquarters: Lyon, US Founded: 2009 Workforce: ~25 Company Working: Fabentech Biotech is a pharmaceutical company that develops and manufactures polyclonal antibody treatments. Its platform is safe, tested, and fully validated on polyclonal antibody technology for fighting high-priority biological agents that could threaten public health. It has many local, national, and international partners, namely the National Institutes of Health (UK), US Army, World Health Organization, and the European Defense Fund, who are supporting its biodefense product development. This is the only company in Europe that is able to produce biodefense solutions while adhering to the most strict international norms
Elusys Therapeutics, Inc
Company Headquarters: New Jersey, US Founded: 1998 Workforce: ~25 Company Working: Elusys Therapeutics, Inc. is a commercial-stage biopharmaceutical company that develops antibody-based products to treat infectious diseases. It has partnerships with renowned biodefense associations, including the Centers for Disease Control and Prevention (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), and the National Institute of Allergy and Infectious Diseases (US). It supplies its anthrax antitoxin products from the Strategic National Stockpile (US). Moreover, it is a wholly owned subsidiary of NightHawk Biosciences (US) and is expanding NightHawk's biodefense space while also complementing NightHawk’s RapidVax platform, which is designed to specifically target emerging biological threats
SIGA Technologies
Company Headquarters: New York, US Founded: 1995 Workforce: ~50 Company Working: SIGA Technologies (SIGA) is a pharmaceutical business at the commercialization stage that develops and offers antiviral treatments for smallpox, monkeypox, cowpox, and vaccinia complications. The company has an established research and development collaboration with US federal entities. It provides countermeasures to the Strategic National Stockpile (SNS) and the Department of Defense (DoD). TPOXX ("oral TPOXX," also known as "tecovirimat" in certain overseas markets) is the Company's lead product, which it distributes to the US government and international governments (including government-affiliated entities). In addition, the Company sells TPOXX intravenous formulation ("IV TPOXX") to the US Government
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Dental Tourism Market